Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of TMI-005 (Apratastat) with Methotrexate in Rheumatoid Arthritis
2004-002215-80Phase 2Completed
- Sponsor
- Wyeth
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apratastat in rheumatoid arthritis (RA), sponsored by Wyeth. Primary endpoint: Clinical response to therapy. Started May 2005; status: completed.
02
Drugs
apratastat
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-002215-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002215-80.